Buffet's Billions: A $360 Million Piece of the Pie for Israeli Drugmaker Teva
Buffet's Billions: A $360 Million Piece of the Pie for Israeli Drugmaker Teva
SUGAR LAND--February 16, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As of late, most headlines dealing with generic giant Teva Pharmaceutical Industries Limited (NYSE:TEVA) (Tel Aviv) have centered on financial woes and massive layoffs. The company is in the midst of a major restructuring plan under the guidance of new President and Chief Executive Officer (CEO) Kare Shulz. So, the news of billionaire Warren Buffet's company Berkshire Hathaway's (NYSE:BRKB) $360 million investment in the company came as a surprise to many.
Within this article: Update on Teva Industries.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion